SCHEMBL8030862

SCHEMBL8030862

CC1CC(=O)c2cc(N)cnc2C1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 10/20 0.56
ALDH1A1 P00352 5/20 0.45
RAB9A P51151 5/20 0.42
NPC1 O15118 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HPGD P15428 2/20 0.42
MAOB P27338 3/20 0.41
KMT2A Q03164 1/20 0.40
USP2 O75604 1/20 0.40
STAT1 P42224 1/20 0.39
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NLRP3 Q96P20 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8029125 0.80 GRM5 (0.56) GRM5ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL9763278 0.80 GRM5 (0.56) GRM5ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL8019557 0.75 GRM5 (0.51) GRM5ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL10536487 0.74 GRM5 (0.50) GRM5ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL10536476 0.74 GRM5 (0.50) GRM5ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL2713936 0.72 GRM5 (1.00) GRM5ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL2717540 0.72 GRM5 (0.69) GRM5ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL2716206 0.71 GRM5 (0.67) GRM5ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL8019571 0.70 GRM5 (0.58) GRM5ALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL9835747 0.69 GRM5 (0.51) GRM5ALDH1A1RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166031-A Substituted tetralins, chromans and related compounds in the treatment of asthma PFIZER INC, (US) 2000-12-26 US disclosed
US-5998451-A LIPOXYGENASE INHIBITORS PFIZER INC (US) 1999-12-07 US disclosed
CN-1024663-C Substituted tetralins for treating asthma PFIZER (US) 1994-05-25 CN disclosed
CN-1021823-C Substituted chroman compounds for treatment of asthma, arthritis and the like PFIZER (US) 1993-08-18 CN disclosed
EP-0313295-B1 SUBSTITUTED TETRALINS, CHROMANS AND RELATED COMPOUNDS IN THE TREATMENT OF ASTHMA, ARTHRITIS AND RELATED DISEASES PFIZER INC. (US) 1993-07-28 EP disclosed
CN-1064864-A The tetraline that replaces and the preparation method of allied compound PFIZER (US) 1992-09-30 CN disclosed
CN-1063489-A Substituted benzotetrahydropyridines and related compounds PFIZER (US) 1992-08-12 CN disclosed
US-5059609-A Lipoxygenase inhibitors; leukotriene receptor blockers; psoriasis; antiulcer agents and myocardial infarctions PFIZER INC. (US) 1991-10-22 US disclosed
CN-1033277-A Substituted tetralinchromans and related compounds for the treatment of asthma PFIZER (US) 1989-06-07 CN disclosed
WO-1989003681-A1 SUBSTITUTED TETRALINS, CHROMANS AND RELATED COMPOUNDS IN THE TREATMENT OF ASTHMA PFIZER INC. (US) 1989-05-05 WO disclosed
CN-1032659-A Substituted tetralins, chromans and like compounds for the treatment of asthma, arthritis and like diseases PFIZER (US) 1989-05-03 CN disclosed
EP-0313295-A2 Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases PFIZER INC. (US) 1989-04-26 EP disclosed
EP-0313296-A2 Substituted chromans and related compounds in the treatment of asthma PFIZER INC. (US) 1989-04-26 EP disclosed